1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    Confident male executive dressed in a dark blue suit leans against a doorway with his arms crossed in the corporate office
    How to invest

    Investing in ASX shares? Why CEO pay DOES matter when misaligned

    | Kate Lee, CFA

    Wonder who topped the highest-paid CEO table?

    Read more »

    A young well-dressed couple at a luxury resort celebrate successful life choices.
    How to invest

    Could investing $10,000 in ASX shares make you a millionaire?

    | James Mickleboro

    Is this the key to becoming wealthy? Let's find out more.

    Read more »

    A woman wearing a bright multi-coloured dress, blue sunglasses and hat stands on a beach laughing with her arms outstretched enjoying herself
    Record Highs

    ASX 200 re-writes history. Which companies are leading the charge?

    | Sebastian Bowen

    The ASX 200 is finishing the week with a bang.

    Read more »

    A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
    Healthcare Shares

    CSL shares: 'Healthy growth at a reasonable price'

    | James Mickleboro

    Bell Potter thinks that investors should be buying this top stock before it's too late.

    Read more »

    A group of young ASX investors sitting around a laptop with an older lady standing behind them explaining how investing works.
    Broker Notes

    10 ASX shares to buy in FY25

    | James Mickleboro

    Analysts say investors should buy these stocks in the new financial year.

    Read more »

    Contented looking man leans back in his chair at his desk and smiles.
    Broker Notes

    Top brokers name 3 ASX shares to buy next week

    | James Mickleboro

    Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

    Read more »

    A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
    Broker Notes

    Brokers name 3 ASX shares to buy now

    | James Mickleboro

    Here's why brokers are feeling bullish about these three shares this week.

    Read more »

    Cropped shot of an attractive young female scientist working on her computer in the laboratory.
    Healthcare Shares

    What happened with the CSL share price in FY 2024?

    | Bernd Struben

    CSL shares didn’t shoot the lights out in 2024 but dividends hit record highs.

    Read more »

    Red percentage sign on blocks on top of each other, symbolising interest rates.
    Broker Notes

    The best ASX 200 shares to buy when interest rates fall

    | James Mickleboro

    Bell Potter thinks investors should be buying these stocks ahead of interest rate cuts.

    Read more »

    A group of people in a corporate setting do a collective high five.
    Broker Notes

    Broker upgrades CSL shares to 'buy' — could they hit $335?

    | Zach Bristow

    Another upgrade for the biotech giant.

    Read more »

    Older couple enjoying the backyard
    Retirement

    3 top ASX retirement shares to buy for FY25

    | James Mickleboro

    Analysts think these stocks could be good additions to a retirement portfolio.

    Read more »

    Donor donates blood in medical clinic. Beautiful European woman of 30 years sits in medical chair looking into camera and smiling.
    Healthcare Shares

    Why the CSL share price could be 'undervalued' at $293

    | Sebastian Bowen

    These experts say CSL shares are primed to shoot higher.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note